News
Divergence Nominated as a Top Biotechnology Company in Toronto
July 8, 2021 – Today we are elated to announce that Divergence has been nominated…
Divergence Launches the Divergence Neuro Platform at ISNR 2021
June 25, 2021 – Earlier this morning at the annual International Society for Neuroregulation &…
Divergence Partners with Neurosity to Sell and Integrate the Crown to the Divergence Platform
June 18, 2021 – We are very excited to announce that Divergence Neuro Technologies Inc.…
Jeff Moore Announced as Board Member and COO for Divergence Neuro Technologies Inc.
June 1, 2021 – Today we are very excited to announce that Jeff Moore has…
Divergence Launches Platform Beta to Pre-registered Users
May 17, 2021 – Today we are very excited to announce that the beta version…
Divergence Announces Dr. Sergio R. Pérez Rosal, Special Advisor of Clinical and Scientific Research Affairs
We are pleased to announce that Dr. Sergio R. Pérez Rosal, (MD) has been appointed…
Divergence Appears with MPP and Ontario NDP Technology Development and Innovation Critic, Chris Glover, on Tech Talks
May 4, 2021 – We are excited to announce that Divergence was featured on the…
Entheon Biomedical Partners with Divergence Neuro Technologies
Divergence is thrilled to announce that it will be a crucial part of this collaboration…
